PROGYNY INC (PGNY) Stock Fundamental Analysis
USA - NASDAQ:PGNY - US74340E1038 - Common Stock
18.43 USD
-0.28 (-1.5%)
18.43 USD
0 (0%)
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 100 industry peers in the Health Care Providers & Services industry. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PGNY is not valued too expensively and it also shows a decent growth rate. These ratings would make PGNY suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year PGNY was profitable.
In the past year PGNY had a positive cash flow from operations.
In the past 5 years PGNY has always been profitable.
Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
PGNY has a better Return On Assets (6.98%) than 88.00% of its industry peers.
The Return On Equity of PGNY (10.31%) is better than 74.00% of its industry peers.
PGNY has a better Return On Invested Capital (10.87%) than 82.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PGNY is in line with the industry average of 9.40%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(10.87%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 10.31% | ||
| ROIC | 10.87% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
Looking at the Profit Margin, with a value of 4.28%, PGNY is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
PGNY's Profit Margin has declined in the last couple of years.
PGNY has a better Operating Margin (6.18%) than 65.00% of its industry peers.
In the last couple of years the Operating Margin of PGNY has grown nicely.
PGNY has a Gross Margin (22.34%) which is in line with its industry peers.
PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.18% | ||
| PM (TTM) | 4.28% | ||
| GM | 22.34% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PGNY is still creating some value.
The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
PGNY has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PGNY has an Altman-Z score of 6.80. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
PGNY's Altman-Z score of 6.80 is amongst the best of the industry. PGNY outperforms 92.00% of its industry peers.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.8 |
ROIC/WACC1.19
WACC9.16%
2.3 Liquidity
A Current Ratio of 2.70 indicates that PGNY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.70, PGNY belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
PGNY has a Quick Ratio of 2.70. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.70, PGNY belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.7 | ||
| Quick Ratio | 2.7 |
3. Growth
3.1 Past
PGNY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.35%.
The Earnings Per Share has been decreasing by -4.77% on average over the past years.
PGNY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.62%.
Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 38.42% on average per year.
EPS 1Y (TTM)-6.35%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%11.76%
Revenue 1Y (TTM)9.62%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.47%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.47% yearly.
Based on estimates for the next years, PGNY will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 31.24, the valuation of PGNY can be described as expensive.
PGNY's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of PGNY to the average of the S&P500 Index (26.51), we can say PGNY is valued inline with the index average.
With a Price/Forward Earnings ratio of 17.83, PGNY is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PGNY is valued a bit cheaper than the industry average as 68.00% of the companies are valued more expensively.
PGNY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.53.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.24 | ||
| Fwd PE | 17.83 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PGNY.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.33 | ||
| EV/EBITDA | 14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of PGNY may justify a higher PE ratio.
PGNY's earnings are expected to grow with 31.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.91
PEG (5Y)N/A
EPS Next 2Y34.66%
EPS Next 3Y31.82%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.43
-0.28 (-1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.25%
Inst Owner Change0.07%
Ins Owners1.34%
Ins Owner Change0.04%
Market Cap1.58B
Revenue(TTM)1.24B
Net Income(TTM)53.12M
Analysts80
Price Target29.29 (58.93%)
Short Float %8.26%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.43%
Min EPS beat(2)-11.77%
Max EPS beat(2)14.63%
EPS beat(4)2
Avg EPS beat(4)-0.31%
Min EPS beat(4)-19.12%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)9.53%
EPS beat(12)9
Avg EPS beat(12)48.1%
EPS beat(16)13
Avg EPS beat(16)104.01%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)1.96%
Max Revenue beat(2)3.19%
Revenue beat(4)3
Avg Revenue beat(4)1.39%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)7
Avg Revenue beat(12)0.46%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)7.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.39%
EPS NY rev (1m)0%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.24 | ||
| Fwd PE | 17.83 | ||
| P/S | 1.28 | ||
| P/FCF | 8.33 | ||
| P/OCF | 7.84 | ||
| P/B | 3.08 | ||
| P/tB | 3.24 | ||
| EV/EBITDA | 14 |
EPS(TTM)0.59
EY3.2%
EPS(NY)1.03
Fwd EY5.61%
FCF(TTM)2.21
FCFY12%
OCF(TTM)2.35
OCFY12.75%
SpS14.44
BVpS5.99
TBVpS5.68
PEG (NY)2.91
PEG (5Y)N/A
Graham Number8.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 10.31% | ||
| ROCE | 14.2% | ||
| ROIC | 10.87% | ||
| ROICexc | 24.96% | ||
| ROICexgc | 28.14% | ||
| OM | 6.18% | ||
| PM (TTM) | 4.28% | ||
| GM | 22.34% | ||
| FCFM | 15.31% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score8
Asset Turnover1.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 293.7% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 250.02% | ||
| Profit Quality | 358.02% | ||
| Current Ratio | 2.7 | ||
| Quick Ratio | 2.7 | ||
| Altman-Z | 6.8 |
F-Score8
WACC9.16%
ROIC/WACC1.19
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.35%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%11.76%
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue 1Y (TTM)9.62%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.47%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
EBIT growth 1Y7.81%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year33.19%
EBIT Next 3Y18.12%
EBIT Next 5Y15.38%
FCF growth 1Y14.92%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y19.24%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 5 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 31.24 and the Price/Book (PB) ratio is 3.08.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 10.72% in the next year.